SK Bioscience's lockup releases hit the market today. A substantial drop in FO can signal a tighter supply for passive funds, increasing the possibility of an overshooting ahead of K200 entry.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.